After a bit of a break, we’re back with more succinct summaries of BMJOG content. As always, there are a fantastic range of articles published in BMJOG within the last month and these can all be accessed free-of-charge on the website. As we head back into blogs, we’re going to take a look at the […]
Category: Uncategorised
Identifying and understanding disease burden in patients with inflammatory bowel disease
After a brief break we return in November for a new blog focusing again on inflammatory bowel disease. In this article the authors take a novel approach to determining the disease burden on patients. Rather than focusing on factors linked to clinician measurable markers of disease activity, such as blood results, faecal calprotectin or endoscopic/histological […]
Revisiting COVID-19; faecal microbiome and the possible consequences of dysbiosis
For May’s blog we are going to focus on a single article from BMJOG, getting a lot of social media attention! In their article on the Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity Hazan et al have clearly tapped into a huge area of interest in […]
Improving patient experience of endoscopy: The Newcastle ENDOPREM™: a validated patient reported experience measure for gastrointestinal endoscopy
In this month’s blog we will focus on a highly innovative and important study, detailing an under appreciated area of importance in endoscopy- measuring patient experience during gastrointestinal procedures. The author’s rationale for the study centred on the lack of patient-centred measures of their own experience, with current measures typically being clinician derived. The study […]
Exclusive enteral nutrition in adult Crohn’s disease, machine learning in capsule endoscopy and dosing of Vedolizumab based on T cell function
In this month’s blog we focus on two recently published articles in BMJOG and discuss a highly impactful basic science manuscript published in Gut which is likely to have implications of dosing of Vedolizumab. As we move forward from COVID-19 and face a potentially difficult winter it remains vital to practice evidence-based speciality medicine. BMJOG, […]
BMJOG Blog: Depression and IBD, artificial intelligence in colorectal cancer, coeliac disease and managing underperforming endoscopists
In this month’s blog, Dr. Christian Selinger, one of BMJOG’s associate editors and consultant Gastroenterologist in Leeds, selects his top publications from the last month and reflects on the findings and impact of these papers. These articles cover a wide-range of topics, reflecting contemporary luminal GI research in IBD, colorectal cancer, coeliac disease and endoscopy. […]